• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

From a constitutional right to a policy of exceptions: Abigail Alliance and the future of access to experimental therapy.

作者信息

Shah Seema, Zettler Patricia

机构信息

Department of Bioethics, Warren G. Magnuson Clinical Center & Division of AIDS, National Institute of Allergy & Infectious Diseases, National Institutes of Health (NIH), USA.

出版信息

Yale J Health Policy Law Ethics. 2010 Winter;10(1):135-96.

PMID:20229846
Abstract
摘要

相似文献

1
From a constitutional right to a policy of exceptions: Abigail Alliance and the future of access to experimental therapy.从宪法权利到例外政策：阿比盖尔联盟与获得实验性疗法的未来
Yale J Health Policy Law Ethics. 2010 Winter;10(1):135-96.
2
Demand grows for early access to promising cancer drugs.
J Natl Cancer Inst. 2002 Nov 20;94(22):1668-70. doi: 10.1093/jnci/94.22.1668.
3
"Right to Try" Laws: The Gap between Experts and Advocates.“尝试权”法律：专家与倡导者之间的差距
Hastings Cent Rep. 2015 May-Jun;45(3):9-10. doi: 10.1002/hast.442.
4
A study in futility: Abigail Alliance for Better Access to Developmental Drugs will not expand access to experimental drugs for the terminally ill.一项徒劳无功的研究：阿比盖尔改善晚期药物可及性联盟不会扩大绝症患者对实验性药物的可及性。
Seton Hall Law Rev. 2009;39(2):559-603.
5
FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.美国食品药品监督管理局扩大治疗用研究性药物可及性的拟议法规：打着改革幌子的现状。
Food Drug Law J. 2009;64(1):183-223.
6
Access before approval--a right to take experimental drugs?批准前获取——有权使用实验性药物？
N Engl J Med. 2006 Aug 3;355(5):437-40. doi: 10.1056/NEJMp068132.
7
New rules for new drugs: the challenge of AIDS to the regulatory process.新药新规：艾滋病对监管程序的挑战。
Milbank Q. 1990;68(Suppl. 1):111-42.
8
An audience with Tatiana Prowell. Interviewed by Asher Mullard.对塔蒂亚娜·普罗韦尔的访谈。采访者：亚瑟·穆拉德。
Nat Rev Drug Discov. 2014 Jun;13(6):410-1. doi: 10.1038/nrd4335.
9
21st Century Cures Act and similar policy efforts: at what cost?《21世纪治愈法案》及类似政策举措：代价几何？
BMJ. 2015 Nov 23;351:h6122. doi: 10.1136/bmj.h6122.
10
Investigational drugs and the constitution.
Hastings Cent Rep. 2006 Nov-Dec;36(6):9-10. doi: 10.1353/hcr.2006.0092.

引用本文的文献

1
Expanding Patient Access to Investigational Drugs: Single Patient Investigational New Drug and the "Right to Try".扩大患者获得试验性药物的机会：单患者试验性新药与“尝试权”
JACC Basic Transl Sci. 2018 May 30;3(2):280-293. doi: 10.1016/j.jacbts.2017.11.007. eCollection 2018 Apr.
2
Expanded Access Programs: Ethical and Practical Considerations for Biopharmaceutical Sponsors.扩大使用计划：生物制药赞助商的伦理与实践考量
Ther Innov Regul Sci. 2015 May;49(3):352-358. doi: 10.1177/2168479015578154. Epub 2015 Apr 2.
3
Going "social" to access experimental and potentially life-saving treatment: an assessment of the policy and online patient advocacy environment for expanded access.
通过“社交”途径获取实验性且可能挽救生命的治疗：对扩大获取途径的政策及在线患者维权环境的评估
BMC Med. 2016 Feb 2;14:17. doi: 10.1186/s12916-016-0568-8.
4
Compassionate use of experimental therapies: who should decide?实验性疗法的同情使用：应由谁来决定？
EMBO Mol Med. 2015 Oct;7(10):1248-50. doi: 10.15252/emmm.201505262.